Effectiveness of Mirtazapine in Alleviating Severe Breathlessness Among Patients With COPD or ILD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial
Lancet Respir Med 2024 Sep 06;[EPub Ahead of Print], IJ Higginson, ST Brown, AO Oluyase, P May, M Maddocks, M Costantini, S Bajwah, C Normand, C Bausewein, ST Simon, K Ryan, DC Currow, MJ Johnson, SP Hart, H Mather, M Krajnik, S Tanzi, L Ghirotto, CE Bolton, P Janowiak, E Turola, CJ Jolley, G Murden, A Wilcock, B Farsides, JM BrownFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.